Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 257-261

  Ochiai, Masayuki ^a   Hayashi, Toshio ^b   Morita, Masahiko ^a   Ina, Koichiro ^b   Maeda, Morihiko ^b   Watanabe, Fumiko ^a   Morishita, Koji ^a  

^a KYOWA HAKKO BIO CO   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial stiffness; Blood pressure; Brachial ankle pulse wave velocity; l arginine; l citrulline; Nitric oxide

Indexed keywords

ARGININE; CITRULLINE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; PLACEBO; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BEDTIME DOSAGE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; GLYCEMIC CONTROL; HEART RATE; HUMAN; HUMAN EXPERIMENT; LIPOLYSIS; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORNING DOSAGE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

ANKLE BRACHIAL INDEX; ARGININE; BLOOD PRESSURE; CITRULLINE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PLACEBOS; PULSATILE FLOW; VASCULAR STIFFNESS;

EID: 84857048398     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.004     Document Type: Article

References (30)

1. E.W. Albrecht, C.A. Stegeman, P. Heeringa, R.H. Henning, and H. van Goor Protective role of endothelial nitric oxide synthase J Pathol 199 2003 8 17
2. J.A. Panza, A.A. Quyyumi, J.E. Brush, and S.E. Epstein Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27
3. B.S. Oemar, M.R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, and T.F. Luscher Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis Circulation 97 1998 2494 2498
4. M.T. Johnstone, S.J. Creager, K.M. Scales, J.A. Cusco, B.K. Lee, and M.A. Creager Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus Circulation 88 1993 2510 2516
5. M. Yambe, H. Tomiyama, and Y. Hirayama Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure Hypertens Res 27 2004 625 631
6. W.W. Nichols, and B.J. Epstein Actions of selected cardiovascular hormones on arterial stiffness and wave reflections Curr Pharm Des 15 2009 304 320
7. M. Hecker, W.C. Sessa, H.J. Harris, E.E. Anggård, and J.R. Vane The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine Proc Natl Acad Sci USA 87 1990 8612 8616
8. T. Hayashi, P.A. Juliet, and H. Matsui-Hirai L-citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits Proc Natl Acad Sci USA 102 2005 13681 13686
9. G. Wu, J.K. Collins, and P. Perkins-Veazie Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats J Nutr 137 2007 2680 2685
10. M.J. Romero, D.H. Platt, and H.E. Tawfik Diabetes-induced coronary vascular dysfunction involves increased arginase activity Circ Res 102 2008 95 102
11. E. Schwedhelm, R. Maas, and R. Freese Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: Impact on nitric oxide metabolism Br J Clin Pharmacol 65 2008 51 59
12. M. Munder Arginase: An emerging key player in the mammalian immune system Br J Pharmacol 158 2009 638 651
13. T. Hayashi, T. Esaki, D. Sumi, T. Mukherjee, A. Iguchi, and G. Chaudhuri Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism Proc Natl Acad Sci USA 103 2006 10485 10490
14. M.J. Romero, D.H. Platt, R.B. Caldwell, and R.W. Caldwell Therapeutic use of citrulline in cardiovascular disease Cardiovasc Drug Rev 24 2006 275 290
15. A. Yamashina, H. Tomiyama, and T. Arai Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk Hypertens Res 26 8 2003 615 622
16. Committee for the establishment of the definition and diagnostic criteria of the metabolic syndrome in Japanese. Metabolic syndrome - Definition and diagnostic criteria in Japan J Jpn Soc Int Med 94 2005 749 809 (in Japanese)
17. T. Hayashi, T. Esaki, and E. Muto Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide Arterioscler Thromb Vasc Biol 20 2000 782 792
18. P. Vallance, A. Leone, and A. Calver Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 8793 1992 572 575
19. A. Yamashina, H. Tomiyama, and K. Takeda Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement Hypertens Res 25 3 2002 359 364
20. M. Hecker, W.C. Sessa, H.J. Harris, E.E. Anggård, and J.R. Vane The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine Proc Natl Acad Sci USA 87 1990 8612 8616
21. J. Sugawara, K. Hayashi, and T. Yokoi Brachial-ankle pulse wave velocity: An index of central arterial stiffness? J Hum Hypertens 19 2005 401 406
22. S. Tsuchikura, T. Shoji, and E. Kimoto Brachial-ankle pulse wave velocity as an index of central arterial stiffness J Atheroscler Thromb 17 2010 658 665
23. A.C. Mendes Ribeiro, T.M. Brunini, J.C. Ellory, and G.E. Mann Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure Cardiovasc Res 49 2001 697 712A
24. T. Hayashi, T. Ishikawa, and M. Naito Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms: Functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators Atherosclerosis 87 1991 23 38
25. T. Hayashi, D. Sumi, and P.A. Juliet Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits Cardiovasc Res 61 2004 339 351
26. B.R. Flam, P.J. Hartmann, M. Harrell-Booth, L.P. Solomonson, and D.C. Eichler Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase Nitric Oxide 5 2001 187 197
27. L.P. Solomonson, B.R. Flam, L.C. Pendleton, B.L. Goodwin, and D.C. Eichler The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells J Exp Biol 206 2003 2083 2087
28. R.H. Boger, and S.M. Bode-Boger The clinical pharmacology of L-arginine Annu Rev Pharmacol Toxicol 41 2001 79 99
29. D. Tsikas, R.H. Boger, J. Sandmann, S.M. Bode-Boger, and J.C. Frolich Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Lett 478 2000 1 3
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150